Global
Our Products
We develop and manufacture vaccines and plasma protein biotherapies. These products help treat and prevent a range of human medical conditions. Read more.
Features
Half Year Results webcast
CSL announce Half Year Results via a streamed presentation - access the recording.
Our Corporate Responsibility 2012
report cover
CSL's fourth report provides a comprehensive account of our global performance in key priority areas.
News
CSL Behring Receives FDA Approval of Kcentra™
30-Apr-2013
Urgent Warfarin Reversal in US Patients with ...
bioCSL Goes Back into Influenza Vaccine Production for Australia
30-Apr-2013
Additional doses are expected to be ready for ...